Home LiteratureArticle Details
PMID: 8245789 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Advanced glycosylation endproduct-specific receptors on human and rat T-lymphocytes mediate synthesis of interferon gamma: role in tissue remodeling.

The Journal of experimental medicine ·Vol. 178 ·No. 6 ·1993-12-01 ·Pages 2165-72

Imani F, Horii Y, Suthanthiran M, Skolnik EY, Makita Z, Sharma V, Sehajpal P, Vlassara H

Abstract

During normal aging and in chronic diabetes the excessive accumulation of reactive glucose-protein or glucose-lipid adducts known as advanced glycosylation endproducts (AGEs) has been shown to induce tissue dysfunction, in part through interaction with AGE-specific receptors on monocyte/macrophages and other cells. Recognizing that circulating lymphocytes trafficking through tissues interact with tissue AGEs, we searched for the expression of AGE-binding sites on peripheral blood T lymphocytes. Resting rat and human T cells bound 125I-AGE-albumin with an affinity of 7.8 x 10(7) M-1, whereas, after stimulation with phytohemagglutinin (PHA) for 48 h, binding affinity increased to 5.8 x 10(8) M-1. Flow cytometric analysis of resting rat T cells using polyclonal antibodies raised against rat liver AGE-binding proteins (p60 and p90) revealed the constitutive expression of both immunoreactivities. The number of resting CD4+ and CD8+ T cells positive for anti-p60 antibody binding (34.2 and 58.5%, respectively) increased to 92 and 90% of cells after 48-h stimulation with PHA. Exposure of PHA-activated T lymphocytes to AGE-albumin enhanced expression of interferon gamma (IFN-gamma) mRNA 10-fold and induced greater elaboration of the mature protein than did exposure to unmodified protein or PHA treatment alone. These data indicate that T cells contain an inducible system of surface receptors for AGE-modified proteins, and that receptor occupancy is linked to lymphokine production. This T cell AGE-receptor system might serve to target lymphocytes to AGE-rich tissues and involve them in the regulation of tissue homeostasis either by assisting in macrophage-dependent clearance of AGE-proteins, or by exerting direct antiproliferative action on mesenchymal cells. Under conditions of excessive AGE-protein and AGE lipid accumulation (e.g., aging and diabetes), enhanced production of AGE-induced IFN-gamma may accelerate immune responses that contribute to tissue injury.

MeSH Terms
Animals Base Sequence DNA Primers Flow Cytometry Gene Expression Glycation End Products, Advanced/metabolism Humans Interferon-gamma/biosynthesis,genetics Ligands Lymphocyte Activation Macrophages/chemistry Male Molecular Sequence Data Monocytes/chemistry RNA, Messenger/genetics Rats Rats, Sprague-Dawley Receptors, Cell Surface/metabolism Up-Regulation
Chemicals
DNA Primers Glycation End Products, Advanced Ligands RNA, Messenger Receptors, Cell Surface Interferon-gamma
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Imani F
Picower Institute for Medical Research, Manhasset, New York 11030.
Horii Y
Suthanthiran M
Skolnik E Y
Makita Z
Sharma V
Sehajpal P
Vlassara H
References (28)
28 references, click to expand
  1. Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response.
    Lab Invest. 1989 Aug;61(2):166-70 PMID: 2787872
  2. Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro.
    Circ Res. 1988 Oct;63(4):712-9 PMID: 3139321
  3. Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties.
    J Exp Med. 1989 Oct 1;170(4):1387-407 PMID: 2551990
  4. Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells.
    J Exp Med. 1989 Nov 1;170(5):1595-608 PMID: 2509626
  5. A novel addition to the T cell repertory. Cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells.
    J Exp Med. 1990 Mar 1;171(3):941-6 PMID: 2307938
  6. Isolation of surface binding protein specific for advanced glycosylation end products from mouse macrophage-derived cell line RAW 264.7.
    Diabetes. 1990 Dec;39(12):1510-8 PMID: 2174009
  7. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging.
    Proc Natl Acad Sci U S A. 1990 Nov;87(22):9010-4 PMID: 2247477
  8. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions.
    Lab Invest. 1991 Jan;64(1):5-15 PMID: 1990208
  9. Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins.
    J Exp Med. 1991 Sep 1;174(3):515-24 PMID: 1651976
  10. Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy.
    J Exp Med. 1991 Oct 1;174(4):931-9 PMID: 1655949
  11. Polyclonal origin of T lymphocytes in human atherosclerotic plaques.
    Lab Invest. 1991 Dec;65(6):654-60 PMID: 1836515
  12. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1.
    Arterioscler Thromb. 1992 Feb;12(2):206-11 PMID: 1531930
  13. Immunochemical detection of advanced glycosylation end products in vivo.
    J Biol Chem. 1992 Mar 15;267(8):5133-8 PMID: 1371995
  14. Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor.
    Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2873-7 PMID: 1313571
  15. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface.
    J Biol Chem. 1992 Jul 25;267(21):14987-97 PMID: 1321822
  16. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins.
    J Biol Chem. 1992 Jul 25;267(21):14998-5004 PMID: 1378843
  17. Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins.
    J Clin Invest. 1992 Aug;90(2):439-46 PMID: 1322940
  18. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.
    Scand J Clin Lab Invest Suppl. 1968;97:77-89 PMID: 4179068
  19. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
    Anal Biochem. 1976 May 7;72:248-54 PMID: 942051
  20. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.
    Biochem Biophys Res Commun. 1978 Feb 28;80(4):849-57 PMID: 637870
  21. Possible role for cell-surface carbohydrate-binding molecules in lymphocyte recirculation.
    J Cell Biol. 1983 Mar;96(3):722-9 PMID: 6833380
  22. Novel macrophage receptor for glucose-modified proteins is distinct from previously described scavenger receptors.
    J Exp Med. 1986 Oct 1;164(4):1301-9 PMID: 3760778
  23. Advanced glycosylation endproducts on erythrocyte cell surface induce receptor-mediated phagocytosis by macrophages. A model for turnover of aging cells.
    J Exp Med. 1987 Aug 1;166(2):539-49 PMID: 3598465
  24. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.
    N Engl J Med. 1988 May 19;318(20):1315-21 PMID: 3283558
  25. The interleukin 2 receptor.
    Adv Immunol. 1988;42:165-79 PMID: 3129919
  26. Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling.
    Science. 1988 Jun 10;240(4858):1546-8 PMID: 3259727
  27. Characterization of a solubilized cell surface binding protein on macrophages specific for proteins modified nonenzymatically by advanced glycosylated end products.
    Arch Biochem Biophys. 1988 Jun;263(2):418-23 PMID: 3377512
  28. Detection of activated T lymphocytes in the human atherosclerotic plaque.
    Am J Pathol. 1989 Jul;135(1):169-75 PMID: 2505620
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1993-12-01
Pages
2165-72
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2191269
Subset
IM
Grants
NIA NIH HHS · AGO8245 · United States
NIA NIH HHS · AGO9453 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com